61755-019-01 |
61755-019 |
HUMAN PRESCRIPTION DRUG |
Inmazeb |
atoltivimab, maftivimab, and odesivimab-ebgn |
INJECTION, SOLUTION |
INTRAVENOUS |
20210729 |
N/A |
BLA |
BLA761169 |
Regeneron Pharmaceuticals, Inc. |
ATOLTIVIMAB; MAFTIVIMAB; ODESIVIMAB |
483.3 mg/14.5mL; 483.3 mg/14.5mL; 483.3 mg/14.5mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (61755-019-01) / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-019-00) |
61755-018-01 |
61755-018 |
HUMAN PRESCRIPTION DRUG |
Inmazeb |
atoltivimab, maftivimab, and odesivimab-ebgn |
INJECTION, SOLUTION |
INTRAVENOUS |
20201014 |
N/A |
BLA |
BLA761169 |
Regeneron Pharmaceuticals, Inc. |
ATOLTIVIMAB; MAFTIVIMAB; ODESIVIMAB |
241.7 mg/14.5mL; 241.7 mg/14.5mL; 241.7 mg/14.5mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (61755-018-01) / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-018-00) |